Compare Medtronic PLC (MDT) vs Mercadolibre Inc (MELI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Mercadolibre Inc — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while Mercadolibre Inc trades at $1,889.85 (market cap $94.13B). The key difference: Medtronic PLC is the larger of the two by market cap, and Medtronic PLC pays a 3.28% dividend while Mercadolibre Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Mercadolibre Inc for 117 Days on average.
| MDT | MELI | |
|---|---|---|
Market Cap | $112.24B | $94.13B |
Volume | 105,663,236 | 273,781 |
Sector | Health | Consumer Cyclical |
52-Week High | $105.35 | $2.36K |
52-Week Low | $73.75 | $1.55K |
Typical Hold Time | 63 Days | 117 Days |
Enterprise Value | $131.58B | $101.77B |
Dividend Yield | 3.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong fundamental performance including three consecutive quarterly earnings beats and a 49-year dividend growth streak. The stock shows bearish technical signals but maintains solid profitability with 13.93% net margins and positive cash flow trends. Recent regulatory approvals for medical devices and raised guidance signal operational momentum despite mixed technical indicators.
Outlook remains positive with analyst consensus at $97.80 (11% upside) and no sell ratings, though technical weakness and increasing debt-to-asset ratios pose near-term risks. The 3.2% dividend yield provides income support while revenue growth acceleration to $37.5B projected for 2026 offers growth potential.
MercadoLibre (MELI) trades at $1,856.66, down 0.86% on the day, with the stock showing strong fundamental growth despite recent earnings volatility. The company maintains robust revenue expansion, reaching $28.89 billion in 2025, while technical indicators show a bullish trend with support at $1,842 and resistance at $1,870. Recent news highlights MercadoLibre's dominant position in Latin American e-commerce and fintech, with new service expansions in Brazil.
MELI presents a compelling growth story with strong analyst support (24 buy ratings, 0 sell) and a consensus price target of $2,170. However, investors face risks from profit margin compression and macroeconomic headwinds in key markets like Argentina, requiring careful monitoring of execution against high valuation multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Mercadolibre Inc
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →
